Testing DR10624 for severe high triglycerides
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests a new injectable drug called DR10624 for people with very high triglyceride levels. It aims to lower triglycerides and reduce the risk of pancreatitis (inflammation of the pancreas).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- Your body mass index (BMI) is between 19 and 45, and you weigh at least 50 kg (110 lbs).
- Your fasting triglycerides (a type of fat in blood) are very high, confirmed by two blood tests taken at least one week apart.
- You have been on a stable, doctor-prescribed lipid-lowering medicine for at least 4 weeks.
- You do not have recent severe pancreatitis, serious liver/kidney/heart disease, or uncontrolled diabetes or high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This trial tests a new drug, DR10624, to see if it can lower high triglycerides and reduce plaque in the carotid artery (the main artery in your neck). It may help people with both conditions who are also overweight.
This trial tests an experimental drug called CS-121 for people with very high triglyceride levels that don't improve with standard treatments. It uses a new gene-editing approach to lower triglycerides and aims to reduce the risk of pancreatitis and other complications.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This study tests whether a GLP-1 medication (a drug that helps control blood sugar and triglycerides) can prevent pancreatitis from coming back in people who had a severe attack caused by very high triglyceride levels. If it works, it could help you avoid future painful attacks.
This trial tests a new injectable drug, JMT202, for people with high triglycerides (a type of fat in the blood). The goal is to see if it safely lowers triglycerides and may reduce heart risk.
Hear when a new Severe Hypertriglyceridemia (sHTG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.